Qiagen N.V.
QGEN
Rangering i aksjer
#2055
Qiagen N.V. provides sample to insight solutions that transform biological... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Aksjekurs
$48.85
Sist synkronisert: 2026-10-20
Markedsverdi
$10.07B
Endring (1 dag)
4.96%
Endring (1 år)
0.61%
Land
NL
Handel Qiagen N.V. (QGEN)
Kategori
Healthcare
Antall utestående aksjer for Qiagen N.V. (QGEN)
Antall utestående aksjer per June 2026: 206.35M
Ifølge Qiagen N.V. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 206.35M. Ved slutten av December 2024 hadde selskapet 216.44M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Qiagen N.V. (QGEN) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 206.35M | -0.77% |
| 2025 | 207.94M | -3.93% |
| 2024 | 216.44M | -0.48% |
| 2023 | 217.49M | -1.48% |
| 2022 | 220.75M | -0.18% |
| 2021 | 221.14M | -0.19% |
| 2020 | 221.57M | 0.73% |
| 2019 | 219.97M | -2.45% |
| 2018 | 225.51M | -1.12% |
| 2017 | 228.07M | 0.97% |
| 2016 | 225.87M | 0.67% |
| 2015 | 224.38M | 0.42% |
| 2014 | 223.43M | -0.80% |
| 2013 | 225.23M | -0.28% |
| 2012 | 225.86M | 0.14% |
| 2011 | 225.55M | 0.47% |
| 2010 | 224.48M | 12.65% |
| 2009 | 199.26M | 5.14% |
| 2008 | 189.51M | 16.83% |
| 2007 | 162.22M | 12.68% |
| 2006 | 143.97M | 1.13% |
| 2005 | 142.36M | 0.80% |
| 2004 | 141.23M | 0.57% |
| 2003 | 140.43M | 0.72% |
| 2002 | 139.43M | 1.28% |
| 2001 | 137.67M | 0.65% |
| 2000 | 136.78M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 79.80% |
US
|
|
| 705.30M | 241.80% |
US
|
|
| 143.28M | -30.56% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 36.66% |
US
|
